Stratall ANRS 12110/Esther trial: results 256 African patients were randomised to clinical or laboratory (CD4 and VL) monitoring and followed for two years Clinical monitoring was not non-inferior; supports WHO recommendations and suggests clinical monitoring alone useful
{}